GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 767 filers reported holding GLAXOSMITHKLINE PLC in Q4 2016. The put-call ratio across all filers is 1.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $1,038,000 | -8.9% | 29,288 | +4.3% | 0.06% | -12.2% |
Q3 2017 | $1,140,000 | -1.6% | 28,089 | +4.5% | 0.07% | -5.1% |
Q2 2017 | $1,159,000 | +4.5% | 26,886 | +2.2% | 0.08% | +5.4% |
Q1 2017 | $1,109,000 | +12.5% | 26,318 | +2.7% | 0.07% | +4.2% |
Q4 2016 | $986,000 | -10.5% | 25,615 | +0.2% | 0.07% | +2.9% |
Q3 2016 | $1,102,000 | +8.4% | 25,553 | +8.9% | 0.07% | +9.5% |
Q2 2016 | $1,017,000 | +11.5% | 23,468 | +4.3% | 0.06% | +12.5% |
Q1 2016 | $912,000 | +0.8% | 22,503 | +0.3% | 0.06% | -23.3% |
Q4 2015 | $905,000 | -1.7% | 22,434 | -6.4% | 0.07% | -6.4% |
Q3 2015 | $921,000 | -14.9% | 23,960 | -7.8% | 0.08% | -12.4% |
Q2 2015 | $1,082,000 | -17.4% | 25,980 | -8.5% | 0.09% | -19.8% |
Q1 2015 | $1,310,000 | +15.4% | 28,404 | +6.9% | 0.11% | +16.8% |
Q4 2014 | $1,135,000 | -10.9% | 26,567 | -4.1% | 0.10% | -19.5% |
Q3 2014 | $1,274,000 | -9.0% | 27,716 | +5.8% | 0.12% | -8.5% |
Q2 2014 | $1,400,000 | -52.9% | 26,192 | -52.9% | 0.13% | -12.8% |
Q1 2014 | $2,970,000 | +100.9% | 55,622 | +100.9% | 0.15% | -2.6% |
Q4 2013 | $1,478,000 | +19.5% | 27,686 | +12.3% | 0.15% | +2.0% |
Q3 2013 | $1,237,000 | +7.6% | 24,658 | +7.1% | 0.15% | -3.9% |
Q2 2013 | $1,150,000 | – | 23,023 | – | 0.16% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KAHN BROTHERS GROUP INC | 1,282,289 | $46,483,403 | 7.25% |
Columbia Asset Management | 9,960 | $361 | 0.08% |
PARK CIRCLE Co | 800 | $29,000 | 0.03% |
PARADIGM ASSET MANAGEMENT CO LLC | 1,800 | $65,250 | 0.02% |
Byrne Asset Management LLC | 56 | $2,000 | 0.00% |
Retirement Group, LLC | 40 | $1,450 | 0.00% |
Bartlett & Co. LLC | 240 | $9 | 0.00% |
HUNTINGTON NATIONAL BANK | 1 | $40 | 0.00% |